{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:24:19Z","timestamp":1792653859491,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vascn.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T12:44:41Z","timestamp":1460465081000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Safety pharmacology studies using EFP and impedance"],"prefix":"10.1016","volume":"81","author":[{"given":"Alison","family":"Obergrussberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Juhasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"St\u00f6lzle-Feix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Beckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Fertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vascn.2016.04.006_bb0005","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1476-5381.2011.01623.x","article-title":"Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment","volume":"165","author":"Abassi","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.04.006_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vascn.2015.04.002","article-title":"Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes","volume":"75","author":"Asakura","year":"2015","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vascn.2013.03.009","article-title":"Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system","volume":"68","author":"Becker","year":"2013","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.04.006_bb0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vascn.2016.04.006_bb0025","first-page":"745","article-title":"Comprehensive in vitro Proarrhythmia Assay, a novel in vitro\/in silico paradigm to detect ventricular proarrhythmic liability: A visionary 21st century initiative","volume":"13","author":"Cavero","year":"2014","journal-title":"Expert Opinion on Drug Safety"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/toxsci\/kfu084","article-title":"High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays","volume":"140","author":"Clements","year":"2014","journal-title":"Toxicological Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/toxsci\/kfv180","article-title":"Bridging functional and structural cardiotoxicity assays using human embryonic stem-cell derived cardiomyocytes for a more comprehensive risk assessment","volume":"148","author":"Clements","year":"2015","journal-title":"Toxicological Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bjp.0706140","article-title":"Pentamidine reduces hERG expression to prolong the QT interval","volume":"145","author":"Cordes","year":"2005","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/mol.111.075135","article-title":"Molecular determinants of pentamidine-induced hERG trafficking inhibition","volume":"81","author":"Dennis","year":"2012","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2211068214562832","article-title":"New easy-to-use hybrid system for extracellular potential and impedance recordings","volume":"20","author":"Doerr","year":"2015","journal-title":"Journal of Laboratory Automation"},{"issue":"4","key":"10.1016\/j.vascn.2016.04.006_bb0055","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.RES.77.4.718","article-title":"High- and low-affinity sites for [3H]dofetilide binding to guinea pig myocytes","volume":"77","author":"Duff","year":"1995","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057115594589","article-title":"A new perspective in the field of cardiac safety testing through the Comprehensive In Vitro Proarrhythmia Assay paradigm","volume":"21","author":"Fermini","year":"2016","journal-title":"Journal of Biomolecular Screening"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/jcm4010102","article-title":"Scalable electrophysiological investigation of iPS cell-derived cardiomyocytes obtained by a lentiviral purification strategy","volume":"4","author":"Friedrichs","year":"2015","journal-title":"Journal of Clinical Medicine"},{"issue":"6455","key":"10.1016\/j.vascn.2016.04.006_bb0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/366591a0","article-title":"A morphological biosensor for mammalian cells","volume":"366","author":"Giaever","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.taap.2015.07.024","article-title":"High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays","volume":"288","author":"Gilchrist","year":"2015","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/toxsci\/kfr158","article-title":"Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell derived cardiomyocytes","volume":"123","author":"Guo","year":"2011","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2016.04.006_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000329966","article-title":"The electrophysiological effects of cardiac glycosides in cardiomyocytes and in guinea pig isolated hearts","volume":"27","author":"Guo","year":"2011","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kft113","article-title":"Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays","volume":"134","author":"Harris","year":"2013","journal-title":"Toxicological Sciences"},{"issue":"10","key":"10.1016\/j.vascn.2016.04.006_bb0095","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1073\/pnas.0936131100","article-title":"Nifedipine facilitates neurotransmitter release independently of calcium channels","volume":"100","author":"Hirasawa","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.vascn.2016.04.006_bb0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/adt.2011.0396","article-title":"Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes","volume":"9","author":"Jonsson","year":"2011","journal-title":"Assay and Drug Development Technologies"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-12-139","article-title":"Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusion","volume":"12","author":"Khaliulin","year":"2014","journal-title":"Journal of Translational Medicine"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/bios5020199","article-title":"Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time","volume":"5","author":"Kho","year":"2015","journal-title":"Biosensors"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2004.06.003","article-title":"Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus pattern","volume":"50","author":"Kirsch","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.104.073692","article-title":"Pentamidine-induced long QT syndrome and block of hERG trafficking","volume":"312","author":"Kuryshev","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.04.006_bb0125","series-title":"Assay guidance manual","article-title":"Cardiomyocyte impedance assays","author":"Lamore","year":"2015"},{"issue":"7","key":"10.1016\/j.vascn.2016.04.006_bb0130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bjp.2008.191","article-title":"Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines","volume":"154","author":"Lu","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2016.04.006_bb0135","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1213\/ane.0b013e3181b01b02","article-title":"A peripherally acting Na(v)1.7 sodium channel blocker reverses hyperalgesia and allodynia on rat models of inflammatory and neuropathic pain","volume":"109","author":"McGowan","year":"2009","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.vascn.2016.04.006_bb0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2011.01558.x","article-title":"Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes","volume":"165","author":"Nalos","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"11_suppl._1","key":"10.1016\/j.vascn.2016.04.006_bb0145","first-page":"S3","article-title":"Screening drug-induced arrhythmia using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays","volume":"128","author":"Navarrete","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.04.006_bb0150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1159\/000188069","article-title":"In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements","volume":"29","author":"Nguemo","year":"2012","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.vascn.2016.04.006_bb0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejphar.2014.06.044","article-title":"hERG trafficking inhibition in drug-induced lethal cardiac arrhythmia","volume":"741","author":"Nogawa","year":"2014","journal-title":"European Journal of Pharmacology"},{"issue":"April","key":"10.1016\/j.vascn.2016.04.006_bb0160","doi-asserted-by":"crossref","first-page":"17623","DOI":"10.1038\/srep17623","article-title":"Quantitative profiling of the effects of vanoxerine on human cardiac ion channels and its application to cardiac risk","volume":"5","author":"Obejero-Paz","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2016.04.006_bb0165","article-title":"Automated patch clamp meets high-throughput screening: 384 cells recorded in parallel on a planar patch clamp module","author":"Obergrussberger","year":"2015","journal-title":"Journal of Laboratory Automation"},{"key":"10.1016\/j.vascn.2016.04.006_bb0170","series-title":"Stem cell-derived models in toxicity","article-title":"Automated patch clamp recordings of human stem cell-derived cardiomyocytes","author":"Obergrussberger","year":"2016"},{"issue":"6","key":"10.1016\/j.vascn.2016.04.006_bb0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/19336950.2015.1079675","article-title":"Novel screening techniques for ion channel targeting drugs","volume":"9","author":"Obergrussberger","year":"2015","journal-title":"Channels"},{"key":"10.1016\/j.vascn.2016.04.006_bb0180","series-title":"Stem cell-derived models in toxicity","article-title":"Combined impedance and extracellular field potential recordings from human stem cell-derived cardiomyocytes","author":"Obergrussberger","year":"2016"},{"issue":"3","key":"10.1016\/j.vascn.2016.04.006_bb0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vascn.2010.01.014","article-title":"The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes","volume":"61","author":"Peng","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12012-014-9268-9","article-title":"Human stem cell-derived cardiomyocytes in cellular impedance assays: Bringing cardiotoxicity screening to the front line","volume":"15","author":"Peters","year":"2014","journal-title":"Cardiovascular Toxicology"},{"issue":"6","key":"10.1016\/j.vascn.2016.04.006_bb0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/adt.2011.442","article-title":"Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications","volume":"10","author":"Peters","year":"2012","journal-title":"Assay and Drug Development Technologies"},{"issue":"17","key":"10.1016\/j.vascn.2016.04.006_bb0200","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1161\/01.CIR.103.17.2207","article-title":"Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs","volume":"103","author":"Pham","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(97)01249-0","article-title":"A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity blockade of the human cardiac potassium channel HERG","volume":"417","author":"Rampe","year":"1997","journal-title":"FEBS Letters"},{"issue":"3","key":"10.1016\/j.vascn.2016.04.006_bb0210","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium","volume":"167","author":"Sager","year":"2014","journal-title":"American Heart Journal"},{"issue":"7083","key":"10.1016\/j.vascn.2016.04.006_bb0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vascn.2016.04.006_bb0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/adt.2014.601","article-title":"Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology","volume":"12","author":"Scheel","year":"2014","journal-title":"Assay and Drug Development Technologies"},{"issue":"2","key":"10.1016\/j.vascn.2016.04.006_bb0225","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(24)39107-4","article-title":"Comparison of L-type calcium channel blockade by nifedipine and\/or cadmium in guinea pig ventricular myocytes","volume":"294","author":"Shen","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"8","key":"10.1016\/j.vascn.2016.04.006_bb0230","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/1087057111413924","article-title":"Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction","volume":"16","author":"Stoelzle","year":"2011","journal-title":"Journal of Biomolecular Screening"},{"key":"10.1016\/j.vascn.2016.04.006_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2011.00076","article-title":"State-of-the-art automated patch clamp devices: Heat activation, action potentials, and high throughput in ion channel screening","volume":"2","author":"Stoelzle","year":"2011","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2016.04.006_bb0240","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9343(87)90774-1","article-title":"Torsade de pointes during administration of pentamidine isethionate","volume":"83","author":"Wharton","year":"1987","journal-title":"The American Journal of Medicine"},{"issue":"6","key":"10.1016\/j.vascn.2016.04.006_bb0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jala.2011.09.002","article-title":"Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System","volume":"16","author":"Xi","year":"2011","journal-title":"Journal of Laboratory Automation"},{"issue":"4","key":"10.1016\/j.vascn.2016.04.006_bb0250","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/biot.200800020","article-title":"The application of cell-based label-free technology in drug discovery","volume":"3","author":"Xi","year":"2008","journal-title":"Biotechnology Journal"},{"key":"10.1016\/j.vascn.2016.04.006_bb0255","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.vascn.2016.04.006_bb0260","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.RES.84.9.989","article-title":"Mechanism of block and identification of the verapamil binding domain to HERG potassium channels","volume":"84","author":"Zhang","year":"1999","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.vascn.2016.04.006_bb0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-3495(98)77782-3","article-title":"Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature","volume":"74","author":"Zhou","year":"1998","journal-title":"Biophysical Journal"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871916300338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871916300338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:01:05Z","timestamp":1761004865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871916300338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":53,"alternative-id":["S1056871916300338"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2016.04.006","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety pharmacology studies using EFP and impedance","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}